Related Experiment Video
Updated: May 3, 2026
Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement
Published on: July 29, 2013
Cross-validation of two commercial methods for volumetric high-resolution dose reconstruction on a phantom for
Vladimir Feygelman1, Cassandra Stambaugh2, Daniel Opp1
1Department of Radiation Oncology, Moffitt Cancer Center, Tampa, USA.
Background And Purpose:
Delta(4) (ScandiDos AB, Uppsala, Sweden) and ArcCHECK with 3DVH software (Sun Nuclear Corp., Melbourne, FL, USA) are commercial quasi-three-dimensional diode dosimetry arrays capable of volumetric measurement-guided dose reconstruction. A method to reconstruct dose for non-coplanar VMAT beams with 3DVH is described. The Delta(4) 3D dose reconstruction on its own phantom for VMAT delivery has not been thoroughly evaluated previously, and we do so by comparison with 3DVH.
Materials And Methods:
Reconstructed volumetric doses for VMAT plans delivered with different table angles were compared between the Delta(4) and 3DVH using gamma analysis.
Results:
The average γ (2% local dose-error normalization/2mm) passing rate comparing the directly measured Delta(4) diode dose with 3DVH was 98.2 ± 1.6% (1SD). The average passing rate for the full volumetric comparison of the reconstructed doses on a homogeneous cylindrical phantom was 95.6 ± 1.5%. No dependence on the table angle was observed.
Conclusions:
Modified 3DVH algorithm is capable of 3D VMAT dose reconstruction on an arbitrary volume for the full range of table angles. Our comparison results between different dosimeters make a compelling case for the use of electronic arrays with high-resolution 3D dose reconstruction as primary means of evaluating spatial dose distributions during IMRT/VMAT verification.
More Related Videos
11:38Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Published on: July 3, 2014
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022